multivalent pain therapeutics (Theravance)

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug Namemultivalent pain therapeutics (Theravance)
Drug Alias Namemultivalent pain therapeutics (Advanced Medicine)AMI-3817
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionVoltage-gated sodium channels modulators
TargetsVoltage-gated sodium channels
Therapy Area/IndicationsPainNeuralgia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesInnoviva Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesInnoviva Inc
Active IndicationsN/A
Inactive IndicationsPainNeuralgia

Other Information

ATC CodeN/A
Related LinksN/A